In the US, buprenorphine to treat opioid use disorder can be prescribed only by qualified clinicians. Policy initiatives and advocacy, such as efforts to remove the training requirements required for buprenorphine prescribing, have commonly focused on enlarging the pool of clinicians allowed to prescribe buprenorphine1; current legislation under consideration in the US Congress would eliminate these requirements.2 However, many trained buprenorphine prescribers are not actively prescribing3 or are treating few patients,4,5 and the overall concentration of patient care among prescribers is not well characterized. We quantified the total amount of buprenorphine care delivered by active prescribers and to what extent that varies across specialties.
Stein BD, Saloner B, Schuler MS, Gurvey J, Sorbero M, Gordon AJ. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US. JAMA. 2021;325(21):2206–2208. doi:10.1001/jama.2021.4469
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: